KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

AbbVie (ABBV) Other Operating Expenses (2016 - 2026)

AbbVie has reported Other Operating Expenses over the past 14 years, most recently at $217.0 million for Q4 2025.

  • Quarterly Other Operating Expenses rose 3000.0% to $217.0 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $4.5 billion through Dec 2025, up 64057.14% year-over-year, with the annual reading at $241.0 million for FY2025, 3342.86% up from the prior year.
  • Other Operating Expenses was $217.0 million for Q4 2025 at AbbVie, up from $24.0 million in the prior quarter.
  • Over five years, Other Operating Expenses peaked at $4.4 billion in Q1 2021 and troughed at -$229.0 million in Q3 2022.
  • The 5-year median for Other Operating Expenses is $118.5 million (2021), against an average of $798.9 million.
  • Year-over-year, Other Operating Expenses crashed 145.8% in 2022 and then skyrocketed 3000.0% in 2025.
  • A 5-year view of Other Operating Expenses shows it stood at $500.0 million in 2021, then crashed by 99.8% to $1.0 million in 2022, then skyrocketed by 16800.0% to $169.0 million in 2023, then crashed by 95.86% to $7.0 million in 2024, then skyrocketed by 3000.0% to $217.0 million in 2025.
  • Per Business Quant, the three most recent readings for ABBV's Other Operating Expenses are $217.0 million (Q4 2025), $24.0 million (Q2 2025), and $4.2 billion (Q1 2025).